Corpus Intelligence IC Memo — ST LUKES HOSPITAL - EASTON CAMPUS 2026-04-26 11:18 UTC
IC Memo — ST LUKES HOSPITAL - EASTON CAMPUS
Investment Committee Memorandum | PA | 29 beds | Grade C | EBITDA uplift $4.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST LUKES HOSPITAL - EASTON CAMPUS

CCN 390162 | NORTHAMPTON, PA | 29 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST LUKES HOSPITAL - EASTON CAMPUS is a 29-bed suburban community hospital in NORTHAMPTON, PA with $55.4M in net patient revenue and a 8.0% operating margin. The hospital serves a payer mix of 31.3% Medicare, 3.7% Medicaid, and 65.0% commercial.

Thesis: Turnaround. Our ML models identify $4.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.0% to 15.4% (+736bps).

Net Revenue HCRIS$55.4M
Current EBITDA COMPUTED$4.4M
Operating Margin COMPUTED8.0%
Occupancy HCRIS45.5%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS12.9%
Distress Probability ML46.1%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
63
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 8.0% places it above the state median. Among 63 size-comparable peers (14-58 beds), the median margin is -1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-58), prioritizing same-state peers. 63 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST LUKES HOSPITAL - EASTON CAM (Target)PA29$55.4M8.0%
OSS ORTHOPAEDIC HOSPITALPA30$149.4M-5.0%
WELLSPAN SURGERY AND REHAB HOSPA25$120.2M2.8%
UPMC LITITZPA36$114.5M14.2%
MINERS MEMORIAL MEDICAL CENTERPA49$107.7M12.4%
LVH-COORDINATED ALLENTOWNPA20$89.6M2.3%
CHARLES COLE MEMORIAL HOSPITALPA25$88.1M-9.0%
ST LUKES HOSPITAL-CARBON CAMPUPA52$86.4M8.1%
POCONO MEDICAL CENTER DICKSON PA40$85.9M0.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$674K+122bp9mo
Clean Claim Rate88.0%96.0%$35K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$674K
Clean Claim Rate
$35K
Total EBITDA Uplift$4.1M
Current EBITDA$4.4M
+ RCM Uplift+$4.1M
Pro Forma EBITDA$8.5M
Current Margin8.0%
Pro Forma Margin15.4%
WC Released (1x)$2.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.8M$70.1M10.26x59.3%
Base (11x exit)10.0x11.0x$6.8M$79.3M11.61x63.3%
Bull Case9.0x11.0x$6.1M$95.0M15.46x72.9%
Bull (12x exit)9.0x12.0x$6.1M$105.4M17.16x76.6%
Bear Case11.0x10.0x$7.5M$47.5M6.32x44.6%
Bear (11x exit)11.0x11.0x$7.5M$54.6M7.28x48.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 63 hospitals with 14-58 beds
  • Same-state prioritization (n=64)
  • Comp margins: P25=-17.2% / P50=-1.5% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.